Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Feeling younger can improve health and extend life.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

A new method was developed to make finasteride for treating hair loss.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Young and adult hamsters both respond similarly to testosterone and finasteride treatments, but young hamsters aren't good for testing the inhibitory activity of a specific enzyme.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

AGA affects many, progresses differently, and early treatment is crucial.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Dutasteride works better than finasteride for preventing and treating prostate cancer.